Ervebo
Merck’s Ervebo has received US FDA approval for use in children 12 months of age and older
SG Tylor
Source – Merck Merck announced that the US Food and Drug Administration (FDA) has granted expanded approval for Ervebo. The ...
most recent
Latest News, Deals, Pharma
Alexion Acquires Voyager’s Preclinical Capsid for Rare Neurological Disease After $1B Pfizer Transfer
Pharma, Clinical Trials, Latest News
Vertex Halts Phase 2 Lung Therapy, Reevaluates DMD Drug’s Clinical Path
Latest News, Clinical Trials, Pharma
Ventyx Halts TYK2 Inhibitor Despite Phase 2 Success, Stock Plummets 70%
Latest News, Pharma
J&J MedTech Plans US Clinical Trials for Ottava Surgical Robot in Late 2024
